James J. Vaughn, Chief Commercial Officer at GENOMIC HEALTH INC (GHDX), sold 4,300 shares at $72.08 ($311K) on 2019-09-09, disclosed to the SEC on 2019-09-11.
Open-market sale of $311k GHDX by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $72.08 | 3,000 | $216K | 69.4% |
| 2 | $73.24 | 1,300 | $95K | 30.6% |
| Total | $72.43 avg | 4,300 | $311K | 100% |
| Filing → |
| GHDX | SELL | 2019-09-11 | $95K | — | Filing → |
| GHDX | SELL | 2019-08-12 | $332K | — | Filing → |
| GHDX | SELL | 2019-08-12 | $273K | — | Filing → |